Matriptase, HAT, and TMPRSS2 Activate the Hemagglutinin of H9N2 Influenza A Viruses

ABSTRACT Influenza A viruses of the subtype H9N2 circulate worldwide and have become highly prevalent in poultry in many countries. Moreover, they are occasionally transmitted to humans, raising concern about their pandemic potential. Influenza virus infectivity requires cleavage of the surface glycoprotein hemagglutinin (HA) at a distinct cleavage site by host cell proteases. H9N2 viruses vary remarkably in the amino acid sequence at the cleavage site, and many isolates from Asia and the Middle East possess the multibasic motifs R-S-S-R and R-S-R-R, but are not activated by furin. Here, we investigated proteolytic activation of the early H9N2 isolate A/turkey/Wisconsin/1/66 (H9-Wisc) and two recent Asian isolates, A/quail/Shantou/782/00 (H9-782) and A/quail/Shantou/2061/00 (H9-2061), containing mono-, di-, and tribasic HA cleavage sites, respectively. All H9N2 isolates were activated by human proteases TMPRSS2 (transmembrane protease, serine S1 member 2) and HAT (human airway trypsin-like protease). Interestingly, H9-782 and H9-2061 were also activated by matriptase, a protease widely expressed in most epithelia with high expression levels in the kidney. Nephrotropism of H9N2 viruses has been observed in chickens, and here we found that H9-782 and H9-2061 were proteolytically activated in canine kidney (MDCK-II) and chicken embryo kidney (CEK) cells, whereas H9-Wisc was not. Virus activation was inhibited by peptide-mimetic inhibitors of matriptase, strongly suggesting that matriptase is responsible for HA cleavage in these kidney cells. Our data demonstrate that H9N2 viruses with R-S-S-R or R-S-R-R cleavage sites are activated by matriptase in addition to HAT and TMPRSS2 and, therefore, can be activated in a wide range of tissues what may affect virus spread, tissue tropism and pathogenicity.

[1]  M. Vey,et al.  Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin‐like endoprotease. , 1992, The EMBO journal.

[2]  D. Pérez,et al.  Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model , 2011, Proceedings of the National Academy of Sciences.

[3]  H. Goto,et al.  A novel mechanism for the acquisition of virulence by a human influenza A virus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Klebe,et al.  New 3-amidinophenylalanine-derived inhibitors of matriptase , 2012 .

[5]  R. Webster,et al.  Live Bird Markets of Bangladesh: H9N2 Viruses and the Near Absence of Highly Pathogenic H5N1 Influenza , 2011, PloS one.

[6]  Y. Sakoda,et al.  H9N2 influenza virus acquires intravenous pathogenicity on the introduction of a pair of di-basic amino acid residues at the cleavage site of the hemagglutinin and consecutive passages in chickens , 2011, Virology Journal.

[7]  Y. Guan,et al.  Cocirculation of Avian H9N2 and Contemporary “Human” H3N2 Influenza A Viruses in Pigs in Southeastern China: Potential for Genetic Reassortment? , 2001, Journal of Virology.

[8]  K. Walters,et al.  An Overlapping Protein-Coding Region in Influenza A Virus Segment 3 Modulates the Host Response , 2012, Science.

[9]  S. Kellokumpu,et al.  Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues , 2001, The Journal of pathology.

[10]  Baljit Singh,et al.  Characterization of Matriptase Expression in Normal Human Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  Hassan Nili,et al.  Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran , 2002, Avian pathology : journal of the W.V.P.A.

[12]  K. Schughart,et al.  TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells , 2010, Journal of Virology.

[13]  S. Farjadian,et al.  Nephropathogenicity of H9N2 Avian Influenza Virus in Commercial Broiler Chickens Following Intratracheal Inoculation , 2011 .

[14]  I. Lindberg,et al.  Highly Potent Inhibitors of Proprotein Convertase Furin as Potential Drugs for Treatment of Infectious Diseases* , 2012, The Journal of Biological Chemistry.

[15]  Y. Bi,et al.  High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses , 2011, Proceedings of the National Academy of Sciences.

[16]  H. Klenk,et al.  New low-viscosity overlay medium for viral plaque assays , 2006, Virology Journal.

[17]  S. H. Marjanmehr,et al.  Pathological Studies of A / Chicken / Tehran / ZMT - 173/99 (H9N2) Influenza Virus in Commercial Broiler Chickens of Iran , 2008 .

[18]  C. Craik,et al.  Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Stella,et al.  In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma. , 2005, International journal of oncology.

[20]  H. Klenk,et al.  Proteolytic Activation of Influenza Viruses by Serine Proteases TMPRSS2 and HAT from Human Airway Epithelium , 2006, Journal of Virology.

[21]  K. Lindblade,et al.  A distinct lineage of influenza A virus from bats , 2012, Proceedings of the National Academy of Sciences.

[22]  W. Bode,et al.  Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase. , 2006, Journal of medicinal chemistry.

[23]  Semi Kim,et al.  Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin , 2009, Journal of Virology.

[24]  D. Pérez,et al.  Minimal molecular constraints for respiratory droplet transmission of an avian–human H9N2 influenza A virus , 2009, Proceedings of the National Academy of Sciences.

[25]  E. Holmes,et al.  Phylogeography and Evolutionary History of Reassortant H9N2 Viruses with Potential Human Health Implications , 2011, Journal of Virology.

[26]  Y. Guan,et al.  Universal primer set for the full-length amplification of all influenza A viruses , 2001, Archives of Virology.

[27]  D. Steinhauer,et al.  Role of hemagglutinin cleavage for the pathogenicity of influenza virus. , 1999, Virology.

[28]  H. Klenk,et al.  Activation of influenza A viruses by trypsin treatment. , 1975, Virology.

[29]  Michael D. Johnson,et al.  Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. , 2009, American journal of physiology. Cell physiology.

[30]  P. Jiao,et al.  Molecular Basis of Efficient Replication and Pathogenicity of H9N2 Avian Influenza Viruses in Mice , 2012, PloS one.

[31]  J. P. Hobson,et al.  Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity* , 2008, Journal of Biological Chemistry.

[32]  S. Malik,et al.  Evaluation of Pathogenic Potential of Avian Influenza Virus Serotype H9N2 in Chickens , 2003, Avian diseases.

[33]  H. Klenk,et al.  Cleavage Activation of the Influenza Virus Hemagglutinin and Its Role in Pathogenesis , 2008 .

[34]  Markus Eickmann,et al.  Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors , 2010, Journal of Virology.

[35]  H. Klenk,et al.  MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. , 2009, Vaccine.

[36]  C. Naeve,et al.  Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? , 1984, Virology.

[37]  Y. Guan,et al.  Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Webster,et al.  H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. , 2001, Virology.

[39]  Hsiao-Chin Chou,et al.  Endogenous Expression of Matriptase in Neural Progenitor Cells Promotes Cell Migration and Neuron Differentiation* , 2010, The Journal of Biological Chemistry.

[40]  R. Leduc,et al.  Probing the substrate specificities of matriptase, matriptase‐2, hepsin and DESC1 with internally quenched fluorescent peptides , 2009, The FEBS journal.

[41]  Hiroshi Kido,et al.  Novel Type II Transmembrane Serine Proteases, MSPL and TMPRSS13, Proteolytically Activate Membrane Fusion Activity of the Hemagglutinin of Highly Pathogenic Avian Influenza Viruses and Induce Their Multicycle Replication , 2010, Journal of Virology.

[42]  G. Whittaker,et al.  Cleavage Activation of the Human-Adapted Influenza Virus Subtypes by Matriptase Reveals both Subtype and Strain Specificities , 2012, Journal of Virology.

[43]  R. Webster,et al.  A DNA transfection system for generation of influenza A virus from eight plasmids. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Gavin J. D. Smith,et al.  The Genesis and Evolution of H9N2 Influenza Viruses in Poultry from Southern China, 2000 to 2005 , 2007, Journal of Virology.

[45]  H. Klenk,et al.  Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors , 2003, Journal of Virology.

[46]  K. Uhland.  Matriptase and its putative role in cancer , 2006, Cellular and Molecular Life Sciences CMLS.

[47]  J. Teifke,et al.  H9 avian influenza reassortant with engineered polybasic cleavage site displays a highly pathogenic phenotype in chicken. , 2011, The Journal of general virology.

[48]  I. Capua,et al.  Avian influenza infection in birds: a challenge and opportunity for the poultry veterinarian. , 2009, Poultry science.

[49]  Y. Guan,et al.  Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. , 2000, Virology.

[50]  T. Bugge,et al.  Matriptase: Potent Proteolysis on the Cell Surface , 2006, Molecular medicine.

[51]  T. Bugge,et al.  Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary. , 2008, The Biochemical journal.

[52]  P. Homme,et al.  Avian influenza virus infections. I. Characteristics of influenza A-turkey-Wisconsin-1966 virus. , 1970, Avian diseases.

[53]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[54]  D. Pérez,et al.  Amino Acid 226 in the Hemagglutinin of H9N2 Influenza Viruses Determines Cell Tropism and Replication in Human Airway Epithelial Cells , 2007, Journal of Virology.

[55]  H. Dadras,et al.  Molecular quantitation of H9N2 avian influenza virus in various organs of broiler chickens using TaqMan real time PCR , 2009, Journal of molecular and genetic medicine : an international journal of biomedical research.

[56]  G. Whittaker,et al.  Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus , 2010, Journal of Virology.

[57]  D. A. Stein,et al.  Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2 , 2010, Journal of Virology.

[58]  David J Stevens,et al.  Structure of the Hemagglutinin Precursor Cleavage Site, a Determinant of Influenza Pathogenicity and the Origin of the Labile Conformation , 1998, Cell.

[59]  A. Fasano,et al.  Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine , 2010, Proceedings of the National Academy of Sciences.

[60]  T. Bugge,et al.  Type II transmembrane serine proteases in development and disease. , 2008, The international journal of biochemistry & cell biology.